Current strategies for armoring chimeric antigen receptor T-cells to overcome barriers of the solid tumor microenvironment
Chimeric antigen receptor (CAR) T-cell therapy is a transformative immunotherapeutic approach, yet its application in solid tumors is hindered by the immunosuppressive tumor microenvironment (TME). The TME restricts T-cell trafficking, impairs effector…